Arrowhead Research Corp (ARWR) 7.28 $ARWR Trade-Ideas:

New Post Public Reply Private Reply Replies (0) Message Board

Apr 26, 2015 at 1:36 PM

Arrowhead Research Corp (ARWR) 7.28 $ARWR

Trade-Ideas: Arrowhead Research (ARWR) Is Today's Strong On High Relative Volume Stock
at The Street - Thu Apr 23, 9:08AM CDT
Trade-Ideas LLC identified Arrowhead Research (ARWR) as a strong on high relative volume candidate
ARWR: 7.28 (+0.05)

Seeking Alpha's Biotech Weekly: Celgene Check-Up, Is Gilead The New Apple?, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Apr 17, 3:00PM CDT
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. This week, contributors geared up for earnings season, highlighted several...
SGYP: 4.01 (-0.10), BIIB: 401.71 (-28.57), ARWR: 7.28 (+0.05), AMGN: 167.91 (-1.26), MYL: 76.06 (+2.37), BMY: 65.80 (-0.20), CNCE: 14.68 (-0.26), CELG: 118.71 (+2.62), ATNM: 2.95 (-0.08), PFS: 18.06 (-0.62), NVIV: 13.03 (+0.64), GILD: 103.69 (-1.52), FWP: 32.03 (-0.06), GWPH: 121.00 (+0.23), IBM: 169.78 (-0.46), BAX: 71.14 (-0.37), AZN: 71.79 (-1.34), TEVA: 64.41 (+1.16)

Where Are The Investors Headed: Complementary Research on Clovis Oncology, DBV Technologies, Cleveland BioLabs, Arrowhead Research and Athenahealth
PR Newswire - Fri Apr 17, 7:25AM CDT
Editor Note: For more information about this release, please scroll to bottom.
DBVT: 26.29 (+0.41), ARWR: 7.28 (+0.05), CLVS: 92.03 (+1.78), CBLI: 3.40 (+0.10), ATHN: 125.30 (+3.30)

Healthcare ratings roundup
Seeking Alpha - at Seeking Alpha - Wed Apr 15, 12:32PM CDT

ICEL: 16.48 (-0.02), ARWR: 7.28 (+0.05), CLVS: 92.03 (+1.78), UNH: 118.69 (+0.43), ABBV: 66.07 (+1.82), NUVA: 43.99 (+0.23)

Buy Arrowhead Research Corporation On The Dip
Clinically Sound Investor - at Seeking Alpha - Wed Apr 15, 6:53AM CDT

ARWR: 7.28 (+0.05)

Nasdaq stocks posting largest percentage decreases
AP - Tue Apr 14, 4:58PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
PFPT: 54.33 (-2.60), ARWR: 7.28 (+0.05), ASPS: 23.24 (+0.76), CTSO: 7.52 (+0.50), SCYX: 9.47 (-0.52), FOMX: 10.46 (-0.44), AKBA: 8.67 (-0.08), TGLS: 11.72 (-0.08), EXA: 11.82 (+0.30), SPKE: 13.00 (-0.04)

Alcatel-Lucent and JPMorgan are big market movers
AP - Tue Apr 14, 3:29PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
NSC: 105.29 (-0.92), ARWR: 7.28 (+0.05), ETH: 25.34 (-1.06), ALU: 3.96 (-0.07), AGI.TO: 8.17 (-0.13), JBLU: 19.89 (+0.14), MGM: 22.00 (-0.08), SHLD: 41.13 (-0.52), FAST: 41.63 (-0.44), JPM: 62.60 (-0.20), QCOM: 68.24 (-0.10), AGI: 6.71 (-0.11), BAS: 8.70 (+0.62), FTK: 14.06 (-0.43), SZYM: 3.79 (-0.11)

Arrowhead Research (ARWR) Stock Falls Today on Jefferies Downgrade
at The Street - Tue Apr 14, 11:51AM CDT
Shares of Arrowhead Research (ARWR) fell Tuesday after Jefferies downgraded the biopharmaceutical company to 'Hold' from 'Buy' and slashed its price target to $9 from $30.
ARWR: 7.28 (+0.05)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Apr 14, 11:45AM CDT

WUBA: 79.42 (+1.16), TANH: 12.29 (+0.54), MTBC: 1.88 (-0.02), ARWR: 7.28 (+0.05), LOJN: 2.41 (-0.11), GNE: 11.37 (+0.70), CBAK: 4.60 (-0.04), HCHC: 11.15 (-0.05), CRDS: 2.50 (-0.06), CHOP: 3.41 (-0.20), NVGN: 6.54 (-0.01), EGY: 2.29 (-0.01), STDY: 9.95 (-0.19), YZC: 10.26 (-0.06), DOVR: 8.43 (-0.05), BRN: 2.81 (+0.15), BLFS: 2.02 (+0.08), BLDR: 12.79 (-0.09), CCCL: 1.31 (-0.02), SZYM: 3.79 (-0.11)

Arrowhead Research (ARWR) Weak On High Volume
at The Street - Tue Apr 14, 9:19AM CDT
Trade-Ideas LLC identified Arrowhead Research (ARWR) as a weak on high relative volume candidate
ARWR: 7.28 (+0.05)

Critical Alerts For GoDaddy, Disney, Arrowhead Research, Merrimack Pharmaceuticals and Organovo Released By InvestorsObserver
PR Newswire - Tue Apr 14, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for GDDY, DIS, ARWR, MACK and ONVO.
MACK: 13.42 (-0.25), ARWR: 7.28 (+0.05), ONVO: 5.19 (+0.12), DIS: 109.53 (+0.53), GDDY: 25.63 (+0.58)

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Tue Apr 14, 8:12AM CDT

NSC: 105.29 (-0.92), ARWR: 7.28 (+0.05), GWPH: 121.00 (+0.23), ALU: 3.96 (-0.07), NVGN: 6.54 (-0.01), BLDR: 12.79 (-0.09), BCLI: 4.14 (+0.02), EGY: 2.29 (-0.01), SZYM: 3.79 (-0.11)

Downgrade Alert for Arrowhead Research (ARWR)
Comtex SmarTrend(R) - Tue Apr 14, 8:06AM CDT
Arrowhead Research (NASDAQ:ARWR) was downgraded from Buy to Hold at Jefferies today. The stock closed yesterday at $8.00 on volume of 8.5 million shares, above average daily volume of 1.5 million. Arrowhead Research (NASDAQ:ARWR) has potential upside of 81.3% based on a current price of $8.00 and analysts' consensus price target of $14.50. The stock should find resistance at its 200-day moving average (MA) of $9.24, as well as support at its 50-day MA of $7.23.
ARWR: 7.28 (+0.05)

Arrowhead Research (ARWR) Stock Rises Today as FDA Allows Study to Proceed
at The Street - Mon Apr 13, 10:40AM CDT
Shares of Arrowhead Research (ARWR) were up in late morning trading Monday after the biopharmaceutical company announced a new permission from the Food and Drug Administration.
ARWR: 7.28 (+0.05)

Why Shares of Arrowhead Research Corp. Briefly Spiked Today
George Budwell, The Motley Fool - Motley Fool - Mon Apr 13, 10:03AM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What : Shares of the clinical-stage biotech Arrowhead...
ARWR: 7.28 (+0.05)

BUYINS.NET: ARWR SqueezeTrigger Price is $8.80. There is $138,779,100 That Short Sellers Still Need To Cover.
M2 - Mon Apr 13, 7:58AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring Arrowhead Research Corp (NASDAQ:ARWR) in real time and just received an alert that ARWR is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 15419900 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $8.80. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
ARWR: 7.28 (+0.05)

Arrowhead cleared to proceed to Phase 2b for hep B candidate
Seeking Alpha - at Seeking Alpha - Mon Apr 13, 6:53AM CDT

ARWR: 7.28 (+0.05)

Arrowhead Cleared to Proceed with Multiple Dose Phase 2b Study of ARC-520
Business Wire - Mon Apr 13, 6:30AM CDT
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that the United States Food and Drug Administration (FDA) informed the Company that it can proceed with a multiple-dose Phase 2b clinical study of ARC-520, its clinical candidate for the treatment of chronic hepatitis B infection, under an investigational new drug (IND) application previously filed with the FDA.
ARWR: 7.28 (+0.05)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Levvy AI: Transforming Hidden Hours into Advisory Gold

Unlocking Hidden Potential: Levvy AI on the Scene Picture this: you're running an accounting shop and drowning in an ocean of endless tasks, manual entries, and those cursed follow-ups. That's probably the daily grind, right? Well, it looks like Levvy has decided to break those shackles. This company, based over there in Brooklyn, is rolling out these fancy Levvy AI...

SKF Vertevo Steps Up Game with Revamped Branding

Spin Cycle: SKF Vertevo's Bold New Chapter Well, they've flipped the switch. SKF Vertevo is stepping out with a brand-spanking-new logo and digital vibe, marking a hefty shift as they strut their stuff post-dismantling from SKF's automotive domain. Now, don't just gloss over this like it's another corporate rebranding snore-fest; this change comes with serious strategic...

Atkins Takes Helm at IEA's Coal Advisory Board

Leadership Shake-up in the Energy World Who would've thought? Randall W. Atkins, Ramaco Resources' top gun, has just bagged a primo gig as the top dog at the International Energy Agency's Coal Industry Advisory Board (CIAB). Named by unanimous vote, he's about to steer this ship through the ever-evolving waters of coal's future. Now, I know some folks roll their eyes at...

Hospitals Face $392M Squeeze Under Medicare's CJR-X

Medicare's CJR-X Challenges Hospitals 2028 is setting up to be a year hospitals across the U.S. remember, not with a smile, but likely with clenched teeth. Medicare's CJR-X model is ready to put about 2,217 hospitals in a financial vise over hip, knee, and ankle replacements. Going into effect on January 1, 2028, this mandate turns health networks' profit dreams into a...

Wincomm & Portwell Unveil Medical AI Tech at MEDICA 2026

MEDICA 2026: Wincomm and Portwell Join Forces November's got one heck of an event lined up with MEDICA 2026, where Wincomm and Portwell are teaming up to showcase what they've got up their sleeves in medical AI computing. This whole shebang runs from November 16 to 19, with their setup in Hall 12, Stand C76, Düsseldorf, Germany. But why should investors care? Because...

DUPR Teams Up with InBody to Elevate Pickleball Fitness

Well, here's a twist in the pickleball world—DUPR and InBody have struck a deal to bring top-notch body composition tech to the ever-expanding universe of pickleballers. They're merging power players from two different worlds to tap into your performance on the court and your wellness off it. Maybe I'm just jaded from too many marketing pitches, but this one could...

EAF Relief Fund Launches After Learjet Disaster

Mobilizing Aid: A Community in Crisis Not every day you wake up to a story that digs into your gut like this one. The folks at the Green Acres Mobile Home Community in Palm Beach County got dealt a raw deal. A Learjet crash shook their world apart on November 1st, leaving nine lives lost on that flight and sending hundreds of residents scrambling from their homes. It's a...

Orvana's Bolivian Ramps & Covenant Pressure

By Henry Turner Updated Nov 2, 2026 Category News Views 117

Orvana's Uphill Journey in Bolivia If you've been tracking Orvana Minerals (TSX: ORV, OTCQX: ORVMF), you know their Bolivian subsidiary, EMIPA, is in the thick of things. Filtration fixes are making noise, and EMIPA's scrambling to get its financial ducks in a row with some urgent maneuvers. Aiming Higher with Don Mario Orvana's Don Mario plant is trucking along with its...

Pudu Robotics: Mowing lawns, Automating Homecare!

Scaling Down: Robotics Meet Your Front Yard Imagine kicking back with a cold one while your new fancy robot takes care of the lawn. Sound like a sci-fi fantasy? Nope, that's the reality Pudu Robotics is peddling with their PUDU TOMO S Series. And boy, they're promising a lot more than just a breather from weekend chores. From Corporate Corridors to Quiet Suburbs Pudu's...

Tarte's Record-Breaking Collab: 60 Seconds to Sellout

When Makeup Meets Pajamas: The Perfect Storm Picture this: a makeup brand and a lifestyle label dreaming up a collaboration that sends consumers into a full-blown frenzy. In a whirlwind that lasted just 60 seconds, tarte's latest partnership with Roller Rabbit blazed through stock, cementing its place as a record-breaking phenomenon. Maureen Kelly, tarte’s intrepid CEO,...